Table 1 Clinical characteristics and total body composition changes
DEXA study | Body morphomics analysis | |
|---|---|---|
Sample size | N = 12 | N = 43 |
Age (years) | 57 (±8.1) | 57 (±7) |
Weight (kg) | 93 (±12.6) | 92 (±17.4) |
BMI | 27.1 (±3.0) | 29.1 (±5) |
LBM (kg) | 59.2 (±7.8) | – |
FBM (kg) | 30.6 (±7.5) | – |
Total psoas area (mm2) | – | 2811 (±726) |
Lean psoas area (mm2) | – | 1407 (±356) |
Male | 12 (100.0) | 36 (95.0) |
Female | 0 (0.0) | 2 (5.0) |
Tumor site | ||
Base of tongue | 6 (50.0) | 20 (53.0) |
Tonsil | 4 (33.3) | 18 (47.0) |
Other | 2 (16.7) | – |
AJCC stage | ||
III | 7 % | 5 % |
IVA | 83 % | 95 % |
IVB | – | – |
Treatment modality, CCRT | 12 (100.0) | 38 (100.0) |
IMRT dose, Gy | 70.0 (±0.0) | 70.0 (±0.0) |